Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Providing an efficient care to the patients of the most severely affected category - intensive care unit (ICU) patients - has become one of the serious problems appearing in the COVID-19 pandemics. A typical patient's clinical portrait in ICU of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of predictors of severe course of disease can lead to different selection of therapeutic strategy, determine the group of risk of patients for severe course of disease, and improve outcomes.
Description: The amount of mechanical ventilation days
Measure: Mechanical ventilation duration Time: 30 daysDescription: The amount of Non-invasive mechanical ventilation days
Measure: Non-invasive Mechanical ventilation duration Time: 30 daysDescription: The dead and survived patients ratio
Measure: Mortality Time: 60 daysDescription: Сomplete blood count
Measure: Сomplete blood count Time: Change from baseline on day 5 during ICU treatmentDescription: Biochemistry analysis
Measure: Biochemistry analysis Time: Change from baseline on day 5 during ICU treatmentDescription: Сomplete blood count
Measure: Сomplete blood count dynamics Time: Change from baseline on day 15 during ICU treatmentDescription: Biochemistry analysis
Measure: Biochemistry analysis dynamics Time: Change from baseline on day 15 during ICU treatmentDescription: Computer tomography of lungs
Measure: Computer tomography Time: Change from baseline on day 5 during ICU treatmentDescription: High-sensitive troponin Т
Measure: High-sensitive troponin Т Time: Change from baseline on day 5 during ICU treatmentDescription: High-sensitive troponin Т
Measure: High-sensitive troponin Т dynamics Time: Change from baseline on day 15 during ICU treatmentDescription: Vitamin D level
Measure: Vitamin D level Time: Change from baseline on day 5 during ICU treatmentDescription: Vitamin D level
Measure: Vitamin D level dynamics Time: Change from baseline on day 15 during ICU treatmentDescription: Immunogram
Measure: Immunogram Time: Change from baseline on day 5 during ICU treatmentDescription: Immunogram
Measure: Immunogram dynamics Time: Change from baseline on day 15 during ICU treatmentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports